Biocure Technology Inc.
CUREX
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 45.60K | 172.00K | 146.90K | 183.30K | 230.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.60K | 172.00K | 146.90K | 183.30K | 230.10K |
| Operating Income | -45.60K | -172.00K | -146.90K | -183.30K | -230.10K |
| Income Before Tax | -74.20K | -203.60K | -176.30K | -175.50K | -188.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.07 | -0.20 | -0.18 | -0.18 | -0.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.20K | -203.60K | -176.30K | -175.50K | -188.70K |
| EBIT | -45.60K | -172.00K | -146.90K | -183.30K | -230.10K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 58.95M | 49.14M | 114.64M | 112.94M | 112.94M |
| Average Diluted Shares Outstanding | 58.95M | 49.14M | 114.64M | 112.94M | 112.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |